| http://www.w3.org/ns/prov#value | - New Milestone for Zevalin - Approval as a First-Line Therapy The indications for using Zevalin and Bexxar were initially limited to refractory cases of non-Hodgkins lymphoma where patients did not respond to Rituxan or other chemotherapy.
|
